Most cited papers from Cancer Council Queensland

Cancer Council Queensland

What are the most cited papers from Cancer Council Queensland?

The most cited paper from Cancer Council Queensland is "Cancer statistics in China, 2015" (Wanqing Chen, Rongshou Zheng, Peter D. Baade et al., 2016), with 18,026 citations. Next come "Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries" (6,323) and "Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines" (1,682).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 182 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Cancer statistics in China, 2015 Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians Open access	25 Jan 2016	18,026
2	Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Claudia Allemani et al. · The Lancet Open access595 authors	31 Jan 2018	6,323
3	Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines Beverley M. Reedman, George Klein · International Journal of Cancer	15 May 1973	1,682
4	Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries Hongmei Zeng et al. · The Lancet Global Health Open access	10 Apr 2018	1,620
5	Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma Toni K. Choueiri et al. · New England Journal of Medicine Open access	25 Sep 2015	1,248
6	Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel Douglas K. Rex, Dennis J. Ahnen, John A. Baron et al. · The American Journal of Gastroenterology Open access	19 Jun 2012	1,116
7	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci The Profile Study et al. · Nature Genetics Open access192 authors	8 Jun 2018	1,025
8	Deep learning in cancer diagnosis, prognosis and treatment selection Khoa Anh Tran, Olga Kondrashova, Andrew P. Bradley et al. · Genome Medicine Open access	27 Sep 2021	963
9	Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial Toni K. Choueiri et al. · The Lancet Oncology Open access	5 Jun 2016	957
10	The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends Danny R. Youlden, Susanna M. Cramb, Peter D. Baade · Journal of Thoracic Oncology Open access	Aug 2008	826
11	The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality Danny R. Youlden, Susanna M. Cramb, Nathan Dunn et al. · Cancer Epidemiology Open access	27 Mar 2012	721
12	Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study John William Yaxley, Geoffrey D. Coughlin, Suzanne K. Chambers et al. · The Lancet	28 Jul 2016	713
13	Cancer survival in C hina, 2003–2005: A population‐based study Hongmei Zeng et al. · International Journal of Cancer Open access	20 Sep 2014	644
14	The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics Ting‐Yuan David Cheng, Susanna M. Cramb, Peter D. Baade et al. · Journal of Thoracic Oncology Open access	27 Jun 2016	621
15	Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial Henry Miles Prince et al. · The Lancet	7 Jun 2017	593
16	Medicinal importance of fungal β-(1→3), (1→6)-glucans Jiezhong Chen, Robert James Seviour · Mycological Research	8 Mar 2007	523
17	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma Satoru Yokoyama et al. · Nature Open access	11 Nov 2011	483
18	Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase Jun Yan, Sandrine Roy, Ann Apolloni et al. · Journal of Biological Chemistry Open access	Sep 1998	481
19	Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study Geoffrey D. Coughlin, John William Yaxley, Suzanne K. Chambers et al. · The Lancet Oncology	17 Jul 2018	475
20	Genome-wide association study identifies three loci associated with melanoma risk D. Timothy Bishop et al. · Nature Genetics Open access	5 Jul 2009	471
21	Controversies around epithelial–mesenchymal plasticity in cancer metastasis Elizabeth D. Williams, Dingcheng Gao, Andrew David Redfern et al. · Nature reviews. Cancer ReviewOpen access	30 Oct 2019	466
22	Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains Sandrine Roy, Robert Luetterforst, Angus Silas Harding et al. · Nature Cell Biology	15 May 1999	455
23	International epidemiology of prostate cancer: Geographical distribution and secular trends Peter D. Baade, Danny R. Youlden, Lauren J. Krnjacki · Molecular Nutrition & Food Research	25 Dec 2008	453
24	H-ras but Not K-ras Traffics to the Plasma Membrane through the Exocytic Pathway Ann Apolloni, Ian Andrew Prior, Margaret R. Lindsay et al. · Molecular and Cellular Biology Open access	Apr 2000	429
25	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Rosalind A. Eeles et al. · Nature Genetics 102 authors	20 Sep 2009	424
26	Sustainable care for children with cancer: a Lancet Oncology Commission Rifat Ali Atun et al. · The Lancet Oncology Open access	30 Mar 2020	368
27	Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial Ruben A. Mesa, Alessandro Maria Vannucchi, Adam J. Mead et al. · The Lancet Haematology Open access	20 Mar 2017	322
28	A randomised controlled trial of a theory-based intervention to improve sun protective behaviour in adolescents ('you can still be HOT in the shade'): study protocol Anna L. Rose Hawkes, Kyra Hamilton, Katherine Marie White et al. · BMC Cancer Open access	3 Jan 2012	313
29	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study Zsofia Kote‐Jarai et al. · Nature Genetics Open access132 authors	10 Jul 2011	293
30	Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial Johann Sebastian De Bono, Niven Mehra, Giorgio V. Scagliotti et al. · The Lancet Oncology Open access	10 Aug 2021	291
31	Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen‐deprivation therapy: a randomised controlled trial Prue Cormie, Daniel Abido Galvao, Nigel A. Spry et al. · British Journal of Urology Open access	27 Jan 2014	281
32	Population-based interventions for the prevention of fall-related injuries in older people Rod McClure, Cathy Turner, Nancye M. Peel et al. · Cochrane Database of Systematic Reviews Open access	17 Jan 2005	276
33	Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature Raymond J. Chan, Vivienne Milch, Fiona M. Crawford-Williams et al. · CA A Cancer Journal for Clinicians ReviewOpen access	26 Jun 2023	273
34	Prostate cancer patients' support and psychological care needs: Survey from a non‐surgical oncology clinic Kathleen C. Lintz, Clare Moynihan, Suzanne K. Steginga et al. · Psycho-Oncology	20 Jun 2003	271
35	Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors David Makarious, K. Horwood, Jermaine I Coward · European Journal of Cancer	27 Jun 2017	266
36	A systematic review of the impact of stigma and nihilism on lung cancer outcomes Suzanne K. Chambers, Jeff Dunn, Stefano Occhipinti et al. · BMC Cancer ReviewOpen access	20 May 2012	263
37	Occupational Sitting Time and Overweight and Obesity in Australian Workers W. Kerry Mummery, Grant Schofield, Rebekah M. Steele et al. · American Journal of Preventive Medicine Open access	9 Jul 2005	257
38	Genome-wide association study identifies three new melanoma susceptibility loci Jennifer H. Barrett et al. · Nature Genetics Open access	9 Oct 2011	250
39	Sunbed use during adolescence and early adulthood is associated with increased risk of early‐onset melanoma Anne Elizabeth Cust, Bruce Konrad Armstrong, Chris Goumas et al. · International Journal of Cancer Open access	28 Jul 2010	247
40	Associations of Leisure-Time Internet and Computer Use With Overweight and Obesity, Physical Activity and Sedentary Behaviors: Cross-Sectional Study Corneel Vandelanotte, Takemi Sugiyama, Paul A. Gardiner et al. · Journal of Medical Internet Research Open access	27 Jul 2009	244
41	Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis Paramita Dasgupta, Chloe Henshaw, Danny R. Youlden et al. · Frontiers in Oncology ReviewOpen access	28 Feb 2020	239
42	Exercise Preserves Physical Function in Prostate Cancer Patients with Bone Metastases Daniel Abido Galvao, Dennis R. Taaffe, Nigel A. Spry et al. · Medicine & Science in Sports & Exercise Open access	15 Oct 2017	233
43	Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002 Michael D Coory, Peter D. Baade, Joanne F. Aitken et al. · Cancer Causes & Control	12 Jan 2006	229
44	Common sequence variants on 20q11.22 confer melanoma susceptibility Kevin M Brown et al. · Nature Genetics Open access	18 May 2008	228
45	Flotillin-1/Reggie-2 Traffics to Surface Raft Domains via a Novel Golgi-independent Pathway Isabel C. Morrow, Shane L. Rea, Sally Martin et al. · Journal of Biological Chemistry Open access	Dec 2002	227
46	The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α Paula Barnard, Nigel A.J. McMillan · Virology Open access	Jul 1999	226
47	Predictors of change in unmet supportive care needs in cancer Michelle McDowell, Stefano Occhipinti, Megan Ferguson et al. · Psycho-Oncology Open access	14 Jul 2009	225
48	The supportive care needs of men with prostate cancer (2000) Suzanne K. Steginga, Stefano Occhipinti, Jeff Dunn et al. · Psycho-Oncology	2001	223
49	The IPOS New International Standard of Quality Cancer Care: integrating the psychosocial domain into routine care Jimmie C. Holland, Maggie Watson, Jeff Dunn · Psycho-Oncology	24 Jun 2011	212
50	Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX Meletios Athanasios Dimopoulos et al. · Haematologica Open access	20 Sep 2018	210

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.